Yun Jung Park

Title: Innovations in Cancer Treatment by Inventor Yun Jung Park

Introduction

Yun Jung Park is a prominent inventor based in Dongducheon-si, South Korea, known for his significant contributions to cancer research and biotechnology. With a total of two patents to his name, Park focuses on developing novel pharmaceutical compositions aimed at preventing and treating cancer.

Latest Patents

The first of Park's latest patents is a pharmaceutical composition containing an endocytic motif and protein transduction domains for preventing or treating cancer. This invention introduces a novel endocytic motif, including a fusion polypeptide represented by an amino acid sequence of SEQ ID NO. 1. It involves a pharmaceutical composition that effectively inhibits c-Met endocytosis and suppresses metastasis, infiltration, angiogenesis, and the growth of various cancer types by targeting the HGF/c-Met signaling pathway.

Park's second patent involves a method for inhibiting cancer metastasis through the administration of the extracellular domain DLK1 or a DLK1-Fc fusion protein. This invention utilizes a recombinant expression vector containing genes for extracellular soluble domain of DLK1 and IgG antibody Fc domain. The resultant DLK1-Fc fusion protein demonstrates marked efficacy in reducing cancer cell migration, showcasing higher stability and superior effects on cancer metastasis inhibition, even at lower concentrations.

Career Highlights

Currently, Yun Jung Park is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he applies his extensive expertise in biotechnology to pioneer groundbreaking solutions in cancer treatment. His innovative approaches and commitment to research make him a valuable asset in his field.

Collaborations

Throughout his career, Park has collaborated with various professionals, including his coworkers Young Woo Park and Ji Hyun Park, strengthening the research environment and enhancing the development of effective cancer therapies.

Conclusion

Yun Jung Park's work exemplifies the potential of innovative research in biotechnology to transform cancer treatment. His latest patents reflect a deep understanding of molecular mechanisms and a strong commitment to advancing medical science, providing hope for effective cancer therapies in the future.